• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素调节的乳腺癌52K组织蛋白酶D:从生物学特性到临床应用

The estrogen-regulated 52K-cathepsin-D in breast cancer: from biology to clinical applications.

作者信息

Rochefort H, Capony F, Augereau P, Cavailles V, Garcia M, Morisset M, Freiss G, Maudelonde T, Vignon F

机构信息

Unité d'Endocrinologie Cellulaire et Moléculaire de l'INSERM (U 158), Montpellier, France.

出版信息

Int J Rad Appl Instrum B. 1987;14(4):377-84. doi: 10.1016/0883-2897(87)90015-8.

DOI:10.1016/0883-2897(87)90015-8
PMID:3654255
Abstract

We have studied estrogen-regulated proteins in an attempt to understand the mechanism by which estrogens stimulate cell proliferation and mammary carcinogenesis. In estrogen receptor positive human breast cancer cell lines (MCF7, ZR75-1) estrogens specifically increase the production into the culture medium of a 52,000 daltons (52K) glycoprotein. Several high affinity monoclonal antibodies to the partially purified secretory 52K protein have allowed to purify to homogeneity this protein and its cellular processed products. The 52K protein has been identified as the secreted precursor of a cathepsin-D like protease bearing mannose-6-phosphate signals and routed to lysosomes via mannose-6-phosphate receptor. The protease is mitogenic in vitro on estrogen deprived MCF7 cells and is able to degrade basement membrane and proteoglycans following its activation. The cellular related proteins, as detected by immunohistochemistry and immunoassay are more concentrated in proliferative mammary ducts than in resting ducts and their concentration in breast cancer cytosol appears to be more correlated with lymph nodes invasion and disease free survival (with S. Thorpe, Copenhagen) than with the estrogen receptor (RE) level. The protein is also produced constitutively by RE-negative cell lines, while in some antiestrogen resistant variants, it becomes inducible by tamoxifen, contrary to the wild type MCF7 cells. Cloning of its cDNA in lambda gt11 has allowed to show that the mRNA is rapidly induced by estrogens and to sequence the protein and compare it to that of the normal human kidney cathepsin-D.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了雌激素调节蛋白,试图了解雌激素刺激细胞增殖和引发乳腺癌的机制。在雌激素受体阳性的人乳腺癌细胞系(MCF7、ZR75-1)中,雌激素能特异性增加一种52,000道尔顿(52K)糖蛋白分泌到培养基中的量。针对部分纯化的分泌型52K蛋白的几种高亲和力单克隆抗体,使得我们能够将该蛋白及其细胞加工产物纯化至同质。52K蛋白已被鉴定为一种组织蛋白酶D样蛋白酶的分泌前体,该蛋白酶带有甘露糖-6-磷酸信号,并通过甘露糖-6-磷酸受体被转运至溶酶体。这种蛋白酶在体外对雌激素剥夺的MCF7细胞具有促有丝分裂作用,激活后能够降解基底膜和蛋白聚糖。通过免疫组织化学和免疫测定检测到的细胞相关蛋白,在增殖的乳腺导管中比在静止的导管中更集中,并且它们在乳腺癌细胞溶质中的浓度似乎与淋巴结侵袭和无病生存期(与哥本哈根的S. Thorpe合作)的相关性比与雌激素受体(RE)水平的相关性更高。RE阴性细胞系也能组成性产生这种蛋白,而在一些抗雌激素耐药变体中,与野生型MCF7细胞相反,它可被他莫昔芬诱导产生。将其cDNA克隆到λgt11中,使得我们能够证明mRNA可被雌激素快速诱导,并对该蛋白进行测序,还能将其与正常人肾组织蛋白酶D的序列进行比较。(摘要截短至250字)

相似文献

1
The estrogen-regulated 52K-cathepsin-D in breast cancer: from biology to clinical applications.雌激素调节的乳腺癌52K组织蛋白酶D:从生物学特性到临床应用
Int J Rad Appl Instrum B. 1987;14(4):377-84. doi: 10.1016/0883-2897(87)90015-8.
2
Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells.乳腺癌细胞分泌的52K组织蛋白酶D前体的结构、功能、调节及临床意义
Biochimie. 1988 Jul;70(7):943-9. doi: 10.1016/0300-9084(88)90236-2.
3
Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?雌激素诱导乳腺癌细胞分泌的溶酶体蛋白酶:在致癌过程中起作用?
J Cell Biochem. 1987 Sep;35(1):17-29. doi: 10.1002/jcb.240350103.
4
Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11.MCF7乳腺癌细胞52K组织蛋白酶D互补脱氧核糖核酸的克隆与测序以及在11号染色体上的定位
Mol Endocrinol. 1988 Feb;2(2):186-92. doi: 10.1210/mend-2-2-186.
5
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].[雌激素、组织蛋白酶D与乳腺癌和卵巢癌转移:侵袭还是增殖?]
C R Seances Soc Biol Fil. 1998;192(2):241-51.
6
Tamoxifen treatment increases the concentration of 52K-cathepsin D and its precursor in breast cancer tissue.他莫昔芬治疗可增加乳腺癌组织中52K-组织蛋白酶D及其前体的浓度。
Cancer. 1989 Apr 1;63(7):1265-70. doi: 10.1002/1097-0142(19890401)63:7<1265::aid-cncr2820630706>3.0.co;2-z.
7
Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.182例乳腺癌细胞溶质中52,000道尔顿组织蛋白酶D的免疫酶测定:与其他预后参数的低相关性
Cancer Res. 1988 Jan 15;48(2):462-6.
8
The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease.
Biochem Biophys Res Commun. 1986 Jul 16;138(1):102-9. doi: 10.1016/0006-291x(86)90252-4.
9
Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells.雌激素和生长因子可诱导乳腺癌细胞分泌的52K-组织蛋白酶D原的信使核糖核酸。
Nucleic Acids Res. 1988 Mar 25;16(5):1903-19. doi: 10.1093/nar/16.5.1903.
10
Cathepsin D in breast cancer.乳腺癌中的组织蛋白酶D
Breast Cancer Res Treat. 1990 Jul;16(1):3-13. doi: 10.1007/BF01806570.

引用本文的文献

1
Prognostic role of high cathepsin D expression in breast cancer: a systematic review and meta-analysis.组织蛋白酶D高表达在乳腺癌中的预后作用:一项系统评价和荟萃分析。
Ther Adv Med Oncol. 2020 Jun 8;12:1758835920927838. doi: 10.1177/1758835920927838. eCollection 2020.
2
Association of tamoxifen resistance and lipid reprogramming in breast cancer.乳腺癌中他莫昔芬耐药与脂代谢重编程的关系。
BMC Cancer. 2018 Aug 24;18(1):850. doi: 10.1186/s12885-018-4757-z.
3
Interrelationship between estradiol and tamoxifen responses for clinical breast carcinoma cells cultured on contact-sensitive plates.
在接触敏感平板上培养的临床乳腺癌细胞中雌二醇与他莫昔芬反应之间的相互关系。
Jpn J Cancer Res. 1994 Jun;85(6):619-25. doi: 10.1111/j.1349-7006.1994.tb02404.x.
4
Detection of P24 protein in human breast cancer: influence of receptor status and oestrogen exposure.人乳腺癌中P24蛋白的检测:受体状态和雌激素暴露的影响
Br J Cancer. 1990 Jun;61(6):886-90. doi: 10.1038/bjc.1990.198.